Movatterモバイル変換


[0]ホーム

URL:


US3894530A - Method for repairing, augmenting, or replacing a body conduit or organ - Google Patents

Method for repairing, augmenting, or replacing a body conduit or organ
Download PDF

Info

Publication number
US3894530A
US3894530AUS376948AUS37694873AUS3894530AUS 3894530 AUS3894530 AUS 3894530AUS 376948 AUS376948 AUS 376948AUS 37694873 AUS37694873 AUS 37694873AUS 3894530 AUS3894530 AUS 3894530A
Authority
US
United States
Prior art keywords
cord
vein
umbilical cord
augmenting
artery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US376948A
Inventor
Irving I Dardik
Herbert Dardik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IndividualfiledCriticalIndividual
Priority to US376948ApriorityCriticalpatent/US3894530A/en
Priority to US05/543,462prioritypatent/US3974526A/en
Priority to US05/563,998prioritypatent/US3988782A/en
Priority to BE158256Aprioritypatent/BE831318A/en
Application grantedgrantedCritical
Publication of US3894530ApublicationCriticalpatent/US3894530A/en
Assigned to DARDIK, SHEILA, PLAINTIFFreassignmentDARDIK, SHEILA, PLAINTIFFCERTIFIED COPY OR ORDER, FILED IN THE SUPERIOR COURT, BERGEN COUNTY, N.J. DISTRIBUTING A 25% INTEREST IN SAID PATENT TO ASSIGNEE FILEDAPRIL 12, 1991.Assignors: DARDIK, IRVING, DEFENDANT D.D.
Anticipated expirationlegal-statusCritical
Expired - Lifetimelegal-statusCriticalCurrent

Links

Classifications

Definitions

Landscapes

Abstract

The umbilical cord is used for grafts in the vascular system or other body conduits, such as the ureter.

Description

United States Patent [1 1 Dardik et al.
[451 July 15,1975
Dardik, 806 Washburn St., Teaneck, NJ. 07666 [22] Filed: July 6, 1973 [21] Appl. No.: 376,948
[52] U.S. Cl 128/1 R; 3/1; 3/l.4; 128/334 R [51] Int. Cl. A61B 19/00; A6lF l/24 [58] Field of Search 3/l, DIG.1, 1.4; 128/334 R, 334 C, 335.5, 335, l R
[56] References Cited UNITED STATES PATENTS 3,408,659 ll/l968 Thiele et al 3/l 3,562,820 2/l97l Braun 3/DIG. 1
OTHER PUBLICATIONS The Use of Umbilical Cord for Reconstruction of Abdominal Wall Defects by Frederick C. Heaton et al., Surgical Forum, Vol. 21, 1970, pp. 56-57.
Preparation and Use of Freeze-Dried Arterial Homografts by O. Creech et al., Annals of Surgery, Vol. 140, No. 1, July, 1954, pp. 35-43.
Primary ExaminerRonald L. Frinks Attorney, Agent, or Firm-Blum Moscovitz Friedman & Kaplan ABSTRACT The umbilical cord is used for grafts in the vascular system or other body conduits, such as the ureter.
5 Claims, No Drawings 1 METHOD FOR REPAIRING, AUGMENTING, OR REPLACING A BODY CONDUIT OR ORGAN A major problem in vascular reconstructive surgery is how effectively to.supply blood to organs and tissues whose blood vessels are inadequate either through congenital defects or acquired disorders such as trauma, arteriosclerosis and other diseases. Various techniques and materials have been devised to excise and replace blood vessels, to bypass blood vessels, and to patch, i.e., widen the channel of vessels. Initially arterial homografts (human arteries) were used to restore continuity but limited supply, inadequate sizes, development of aneurysms and atherosclerosis necessitated the search for a better substitute. A great advance was the development of the partially porous and pliable plastic cloth graft.
The following is a list of the various problems which one runs into with artificially made grafts:
1. Infection in a foreign body graft is catastrophic,
often leading to hemorrhage, sepsis and death.
2. The inner lining is thrombogenic, predisposed to clotting of the graft and distal embolism of the clot.
3. The rigidity of cloth grafts may result in twisting and kinking, especially in areas of crossing a joint.
4. Because of clotting difficulties, smaller caliber artificial grafts are frequently unsuccessful.
The many problems posed by artificially manufactured prostheses have led investigators again to seek newer and better methods. These include new techniques of cleaning out an artery such as carbodissection, widening arteries by dilatation, development of bovine heterografts, creating collagen tubes within the recipient patient for later use as a graft (Silicone Mandrel).
Saphenous veins, both autografts (patient is donor) and allografts or homografts (from another human), are now being used to advantage. However, there are problems of unavailability, small size, non uniform caliber, time required for harvesting, intraluminal valves and easy twisting leading to occlusion. The number of new methods being continually devised attests to the need for a better material.
According to the present invention, the structures of the human umbilical cord are used for grafts in the vascular system or other body conduits such as the ureter, in mammals, particularly primates, including man. At birth, after division from the baby, the cord itself is traditionally discarded. The umbilical cord is composed of a vein and two arteries surrounded by a substance called Whartons jelly. It varies in length from inches to almost 2 feet. It is highly flexible and strong. Both arteries and the vein are suitable for use in surgery. Composite grafts and patches can be made in various sizes and shapes. A list of uses follows, either as a conduit or as a patch of any kind in the body:
1. Arterial substitute 2. Vein substitute 3. Ureter substitute 4. Common bile duct substitute 5. As an arteriovenous fistula for hemodialysis 6. As a patch to close any visceral or vascular defect, or to wrap around and protect a suture line of any kind.
The umbilical cord may be used fresh or as a stored homograft (frozen or in a preservative). It may require treatment with antibiotics or other chemicals or drugs and x-ray treatment for sterilization. It may be antigenic and require treatment, for example with enzymes, to remove any antigenic substances. The cord may be freeze dried or stored in a cold environment or preserved in other known ways as to be used as an autograft if necessary for the baby whenever needed at a future date. The cord may be somewhat coiled and may require mechanical or chemical techniques to straighten it out if necessary. Cords from premature babies or from early pregnancy can be used (i.e., in
smaller vessels).
The advantages of using umbilical vessels as a conduit or a patch are as follows:
1. easy availability 2. marked flexibility 3. marked strength 4. highly smooth, natural inner lining may inhibit clotting 5. less likely to become infected 6. relative lack of antigenicity 7. uniform diameter 8. variable size available for both large and small vessels 9. good length 10. contains 3 vessels each of which can be used EXAMPLE The following example illustrates the technique of vascular surgical interposition of the umbilical cord vessel derived from the human, into the abdominal aorta of an animal, for example a dog and a baboon.
The animal, in this case a baboon, was prepared under general anesthesia and sterile conditions for making an abdominal incision. The baboon was prepared and shaved and a longitudinal incision was made in the midline of the abdomen. The incision extended from the xythoid to the pubic area and was carried down through the midline and into the peritoneal cavity. Bleeding vessels were clamped and ligated with 3-0 plyglycollic acid sutures. The peritoneal cavity was entered and the viscera and bowel were explored for any other diseases. The animal was found to be normal. The bowel and viscera were walled off with cloth pads and retractors. The peritoneum overlying the aorta was incised and the aorta immobilized by sharp and blunt dissection. Lumbar arteries were individually clamped and ligated with 3-0 silk suture so that the segment of abdominal aorta extending from the infra-renal arteries to the bifurcation of the aorta was immobilized. The entire segment of abdominal aorta was thus made available for transplant of the umbilical cord. During preparation of the abdominal aorta of the baboon, another investigator had taken the umbilical cord of an infant (human) that had been born two hours prior to the surgical intervention of the baboon. The cord had been delivered and taken in its entirety and transported in sterile saline solution, packed in ice. The purpose of freezing the umbilical cord in ice was to prevent any further decomposition of the cord structure. The cord, prior to insertion, was washed and irrigated numerous times with sterile Collins solution with antibiotics, in this particular instance, 1 percent cephalosporin solution and 25,000 units of bacitracin per liter of solution. The blood was thoroughly washed out from within the vessels of the cord and the cord was also irrigated with a 1 percent heparin anticoagulant solution. Following this thorough cleansing of the cord, one end of the umbilical vein within the cord which was to be used as the transplant was clamped with a clamp and through the other end a red rubber catheter, No. 14 French, was introduced and the vein was distended. At this point a suitable segment of umbilical graft, approximately 5 centimeters in length, was selected for excision. This segment of cord was then sterilely handled and placed into the operating field. At this point the animal was heparinized with 2,500 units of aqueous heparin given intravenously. The abdominal aorta was then clamped proximally and distally to the segment to be resected. A segment of approximately 3 centimeters in length was resected from the abdominal aorta and an end-toend anastomosis was performed between host aorta and donor umbilical vein, first using continuous 6-0 prolene suture which is a nylon monofilament suture. The distal anastomosis was then performed following flushing of the aorta to rid it of any clot material and debris. Following completion of anastomosis the distal and then the proximal clamps were removed. It was noted that there was no bleeding between the interstices of the sutures, which is unusual, and is felt to be due to the strength and self-sealing gelatinous qualities of the cord structure. Excellent pulses were noted to be present in the graft as well as the distal iliac vessels. The area was lavaged with with saline and suctioned. The retroperitoneum was closed with interrupted 3-0 polyglycollic acid sutures and the viscera was replaced. The animal, throughout the procedure thus far, was stable; the respiration and vital signs were normal. The abdominal wall was then closed in layers using continuous 0 silk for the posterior fascia and peritoneum and interrupted 2-0 silk sutures for the anterior fascia. The skin was approximated with continuous 3-0 nylon suture. The anesthesia used in this procedure was nembutal. The blood loss estimated during the procedure was approximately 50 to cc. The animal tolerated the procedure well and awoke within 30 minutes. Postoperatively on the following day the animal was sitting and walking in its cage, and on the third postoperative day was eating its regular diet and was allowed out of its cage to roam around and climb up and down the walls, and appearedto be in excellent health. The legs were warm and pulses were intact in the extremities.
A number of procedures will become apparent to those skilled in the art. If desired or necessary, the vein or artery of the umbilical cord may be split longitudinally and formed into composites of larger diameter. The umbilical cord or a portion thereof may be used to reinforce, support or seal a weakened area or defect of any body structure, such as the heart, the heart valves or urinary bladder. Such procedures are included within the scope of the claims.
I claim:
1. A method for repairing, augmenting or replacing a vein or artery of the body of a primate which comprises suturing or otherwise securing a portion of a vein or artery of an umbilical cord of a primate into or onto the wall of such body vein or artery.
2. A method as described in claim 1 wherein the umbilical cord is from a human infant.
3. A method as described in claim 1 wherein an artery of the body is repaired, augmented or replaced.
4. A method as described in claim 1 wherein the cord is from a human and said body is that of a primate other than the donor.
5. A method as described in claim 1 wherein a vein of the body is repaired, augmented or replaced.

Claims (5)

US376948A1973-07-061973-07-06Method for repairing, augmenting, or replacing a body conduit or organExpired - LifetimeUS3894530A (en)

Priority Applications (4)

Application NumberPriority DateFiling DateTitle
US376948AUS3894530A (en)1973-07-061973-07-06Method for repairing, augmenting, or replacing a body conduit or organ
US05/543,462US3974526A (en)1973-07-061975-01-23Vascular prostheses and process for producing the same
US05/563,998US3988782A (en)1973-07-061975-04-01Non-antigenic, non-thrombogenic infection-resistant grafts from umbilical cord vessels and process for preparing and using same
BE158256ABE831318A (en)1973-07-061975-07-11 IMPROVEMENTS TO ELEMENTS USED IN SURGICAL TRANSPLANTS

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
US376948AUS3894530A (en)1973-07-061973-07-06Method for repairing, augmenting, or replacing a body conduit or organ

Related Child Applications (1)

Application NumberTitlePriority DateFiling Date
US05/543,462Continuation-In-PartUS3974526A (en)1973-07-061975-01-23Vascular prostheses and process for producing the same

Publications (1)

Publication NumberPublication Date
US3894530Atrue US3894530A (en)1975-07-15

Family

ID=23487154

Family Applications (1)

Application NumberTitlePriority DateFiling Date
US376948AExpired - LifetimeUS3894530A (en)1973-07-061973-07-06Method for repairing, augmenting, or replacing a body conduit or organ

Country Status (1)

CountryLink
US (1)US3894530A (en)

Cited By (30)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US3974526A (en)*1973-07-061976-08-17Dardik Irving IVascular prostheses and process for producing the same
WO1982000091A1 (en)*1980-07-011982-01-21V KetharanathanVascular prostheses
WO1982004390A1 (en)*1981-06-101982-12-23Kenneth Z KurlandMeans and method of implanting bioprosthetics
EP0070328A1 (en)*1981-07-211983-01-26Theurer, Karl Eugen, Prof.Dr.med.Use of egg membranes and umbilical cord in unmodified or modified form
US4487567A (en)*1983-03-241984-12-11Possis Medical, Inc.Apparatus for making a vascular graft
US4546499A (en)*1982-12-131985-10-15Possis Medical, Inc.Method of supplying blood to blood receiving vessels
US4915893A (en)*1982-07-161990-04-10Medtronic, Inc.Method of preparing polyester filament material
US4990131A (en)*1987-09-011991-02-05Herbert DardikTubular prostheses for vascular reconstructive surgery and process for preparing same
US5110852A (en)*1982-07-161992-05-05Rijksuniversiteit Te GroningenFilament material polylactide mixtures
US5114672A (en)*1990-08-271992-05-19Cryo-Cell International, Inc.Method for preserving blood fluid
WO1997003624A1 (en)*1995-07-191997-02-06Renan UflackerAdjustable and retrievable graft and graft delivery system for stent-graft system and methods of implantation
WO1998025543A1 (en)1996-12-101998-06-18Purdue Research FoundationTubular submucosal graft constructs
US5865723A (en)*1995-12-291999-02-02Ramus Medical TechnologiesMethod and apparatus for forming vascular prostheses
US6077217A (en)*1997-06-252000-06-20Ramus Medical Technologies, Inc.System and method for assembling graft structures
US20020040246A1 (en)*1991-08-122002-04-04Bonutti Peter M.Tissue press and system
US20020055755A1 (en)*1990-06-282002-05-09Bonutti Peter M.Apparatus and method for tissue removal
US6494904B1 (en)1996-12-272002-12-17Ramus Medical TechnologiesMethod and apparatus for forming vascular prostheses
US20030050708A1 (en)*1991-08-122003-03-13Bonutti Peter M.Tissue grafting material
US20040126404A1 (en)*1998-08-212004-07-01University Of Queensland Of St. LuciaImplant material
US6990982B1 (en)1990-06-282006-01-31Bonutti Ip, LlcMethod for harvesting and processing cells from tissue fragments
US7294144B1 (en)*1998-08-102007-11-13Schneider James RPreserved implantable vessel derived from a human umbilical cord or placenta
WO2008042441A1 (en)*2006-10-032008-04-10Anthrogenesis CorporationUse of umbilical cord biomaterial for ocular surgery
US20080268017A1 (en)*1998-08-212008-10-30The University Of Queensland Of St. LuciaMethod of producing tissue by placing a molding support within a body cavity
US8747439B2 (en)2000-03-132014-06-10P Tech, LlcMethod of using ultrasonic vibration to secure body tissue with fastening element
US8808329B2 (en)1998-02-062014-08-19Bonutti Skeletal Innovations LlcApparatus and method for securing a portion of a body
US8814902B2 (en)2000-05-032014-08-26Bonutti Skeletal Innovations LlcMethod of securing body tissue
US8845687B2 (en)1996-08-192014-09-30Bonutti Skeletal Innovations LlcAnchor for securing a suture
US8845699B2 (en)1999-08-092014-09-30Bonutti Skeletal Innovations LlcMethod of securing tissue
US9770238B2 (en)2001-12-032017-09-26P Tech, LlcMagnetic positioning apparatus
US9814563B1 (en)*2014-04-252017-11-14David M. HogansonHemodynamically optimized shunt

Citations (2)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US3408659A (en)*1964-07-251968-11-05Thiele HeinrichArtificial blood vessels and process of making same
US3562820A (en)*1966-08-221971-02-16Bernhard BraunTubular sheet and strip form prostheses on a basis of biological tissue

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US3408659A (en)*1964-07-251968-11-05Thiele HeinrichArtificial blood vessels and process of making same
US3562820A (en)*1966-08-221971-02-16Bernhard BraunTubular sheet and strip form prostheses on a basis of biological tissue

Cited By (48)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US3974526A (en)*1973-07-061976-08-17Dardik Irving IVascular prostheses and process for producing the same
WO1982000091A1 (en)*1980-07-011982-01-21V KetharanathanVascular prostheses
US4466139A (en)*1980-07-011984-08-21Vettivetpillai KetharanathanVascular prostheses
WO1982004390A1 (en)*1981-06-101982-12-23Kenneth Z KurlandMeans and method of implanting bioprosthetics
US4400833A (en)*1981-06-101983-08-30Kurland Kenneth ZMeans and method of implanting bioprosthetics
EP0070328A1 (en)*1981-07-211983-01-26Theurer, Karl Eugen, Prof.Dr.med.Use of egg membranes and umbilical cord in unmodified or modified form
US5110852A (en)*1982-07-161992-05-05Rijksuniversiteit Te GroningenFilament material polylactide mixtures
US4915893A (en)*1982-07-161990-04-10Medtronic, Inc.Method of preparing polyester filament material
US4546499A (en)*1982-12-131985-10-15Possis Medical, Inc.Method of supplying blood to blood receiving vessels
US4562597A (en)*1982-12-131986-01-07Possis Medical, Inc.Method of supplying blood to blood receiving vessels
US4601718A (en)*1982-12-131986-07-22Possis Medical, Inc.Vascular graft and blood supply method
US4487567A (en)*1983-03-241984-12-11Possis Medical, Inc.Apparatus for making a vascular graft
US4990131A (en)*1987-09-011991-02-05Herbert DardikTubular prostheses for vascular reconstructive surgery and process for preparing same
US20020055755A1 (en)*1990-06-282002-05-09Bonutti Peter M.Apparatus and method for tissue removal
US7134437B2 (en)1990-06-282006-11-14Bonutti Ip, LlcMethod for utilizing human tissue
US6990982B1 (en)1990-06-282006-01-31Bonutti Ip, LlcMethod for harvesting and processing cells from tissue fragments
US7896880B2 (en)1990-06-282011-03-01P Tech, LlcApparatus and method for tissue removal
US20020099401A1 (en)*1990-06-282002-07-25Bonutti Petel M.Apparatus and method for tissue removal
US5114672A (en)*1990-08-271992-05-19Cryo-Cell International, Inc.Method for preserving blood fluid
US6630000B1 (en)*1991-08-122003-10-07Bonutti 2003 Trust-AMethod of using body tissue
US20040172140A1 (en)*1991-08-122004-09-02Bonutti Peter M.Tissue stabilizing implant
US20020040246A1 (en)*1991-08-122002-04-04Bonutti Peter M.Tissue press and system
US7070557B2 (en)1991-08-122006-07-04Marctec, LlcTissue graft material and method of making
US6989029B2 (en)1991-08-122006-01-24Bonutti Ip, LlcTissue cage
US6905517B2 (en)1991-08-122005-06-14Bonutti Ip, LlpTissue grafting material
US20030050708A1 (en)*1991-08-122003-03-13Bonutti Peter M.Tissue grafting material
US20030130744A1 (en)*1991-08-122003-07-10Bonutti Peter M.Tissue cage
US7462200B2 (en)1991-08-122008-12-09Marctec, LlcMethod for tissue grafting
US7727283B2 (en)1991-08-122010-06-01P Tech, Llc.Tissue stabilizing implant method
WO1997003624A1 (en)*1995-07-191997-02-06Renan UflackerAdjustable and retrievable graft and graft delivery system for stent-graft system and methods of implantation
US5776186A (en)*1995-07-191998-07-07Endotex Interventional Systems, Inc.Adjustable and retrievable graft and graft delivery system for stent-graft system and methods of implantation
US5713948A (en)*1995-07-191998-02-03Uflacker; RenanAdjustable and retrievable graft and graft delivery system for stent-graft system
US5865723A (en)*1995-12-291999-02-02Ramus Medical TechnologiesMethod and apparatus for forming vascular prostheses
US8845687B2 (en)1996-08-192014-09-30Bonutti Skeletal Innovations LlcAnchor for securing a suture
WO1998025546A1 (en)1996-12-101998-06-18Cook Biotech, Inc.Tubular grafts from purified submucosa
WO1998025543A1 (en)1996-12-101998-06-18Purdue Research FoundationTubular submucosal graft constructs
US6494904B1 (en)1996-12-272002-12-17Ramus Medical TechnologiesMethod and apparatus for forming vascular prostheses
US6077217A (en)*1997-06-252000-06-20Ramus Medical Technologies, Inc.System and method for assembling graft structures
US8808329B2 (en)1998-02-062014-08-19Bonutti Skeletal Innovations LlcApparatus and method for securing a portion of a body
US7294144B1 (en)*1998-08-102007-11-13Schneider James RPreserved implantable vessel derived from a human umbilical cord or placenta
US20080268017A1 (en)*1998-08-212008-10-30The University Of Queensland Of St. LuciaMethod of producing tissue by placing a molding support within a body cavity
US20040126404A1 (en)*1998-08-212004-07-01University Of Queensland Of St. LuciaImplant material
US8845699B2 (en)1999-08-092014-09-30Bonutti Skeletal Innovations LlcMethod of securing tissue
US8747439B2 (en)2000-03-132014-06-10P Tech, LlcMethod of using ultrasonic vibration to secure body tissue with fastening element
US8814902B2 (en)2000-05-032014-08-26Bonutti Skeletal Innovations LlcMethod of securing body tissue
US9770238B2 (en)2001-12-032017-09-26P Tech, LlcMagnetic positioning apparatus
WO2008042441A1 (en)*2006-10-032008-04-10Anthrogenesis CorporationUse of umbilical cord biomaterial for ocular surgery
US9814563B1 (en)*2014-04-252017-11-14David M. HogansonHemodynamically optimized shunt

Similar Documents

PublicationPublication DateTitle
US3894530A (en)Method for repairing, augmenting, or replacing a body conduit or organ
US3974526A (en)Vascular prostheses and process for producing the same
US3988782A (en)Non-antigenic, non-thrombogenic infection-resistant grafts from umbilical cord vessels and process for preparing and using same
CA2273250C (en)Stent grafts containing purified submucosa
Dardik et al.Successful arterial substitution with modified human umbilical vein
Lam et al.Resection of the descending thoracic aorta for aneurysm: a report of the use of a homograft in a case and an experimental study
US5131908A (en)Tubular prosthesis for vascular reconstructive surgery and process for preparing same
US4319363A (en)Vascular prostheses
US4990131A (en)Tubular prostheses for vascular reconstructive surgery and process for preparing same
US5078735A (en)Prosthetic grafting method for bypass surgery
CN101541263A (en)Tissue synthesis-biomaterial hybrid medical device
US20100179639A1 (en)Vascular implant
Nakagawa et al.Clinical trial of new polyurethane vascular grafts for hemodialysis: compared with expanded polytetrafluoroethylene grafts
CA1055843A (en)Non-antigenic, non-thrombogenic infection-resistant grafts from umbilical cord vessels and process for preparing and using same
Julian et al.Dacron tube and bifurcation arterial prostheses produced to specification: II. Continued clinical use and the addition of microcrimping
Benjamin et al.Polyvinyl sponge in experimental surgery
US7294144B1 (en)Preserved implantable vessel derived from a human umbilical cord or placenta
Hirsch et al.The use of stabilized human umbilical vein for femoropopliteal bypass. Experience with 133 operations with 5-year follow-up
Sanger et al.The use of artificial fiber as an artery substitute
Santiago-Delpin et al.Experimental and clinical use of polytetrafluoroethylene vascular grafts
CN107432954B (en)Preparation method of novel biological acellular implant material
RU2283622C2 (en)Method for hiding circular skin defects of inferior vena cava with plastic operation
Hardy et al.An acrylate-amide foam arterial prosthesis
RU2818619C2 (en)Method for plastic reconstruction of a renal vein defect with a fragment of a falciform ligament of liver
Shucksmith et al.Late results of arterial reconstructive surgery

Legal Events

DateCodeTitleDescription
PSPatent suit(s) filed
ASAssignment

Owner name:DARDIK, SHEILA, PLAINTIFF

Free format text:CERTIFIED COPY OR ORDER, FILED IN THE SUPERIOR COURT, BERGEN COUNTY, N.J. DISTRIBUTING A 25% INTEREST IN SAID PATENT TO ASSIGNEE FILEDAPRIL 12, 1991.;ASSIGNOR:DARDIK, IRVING, DEFENDANT D.D.;REEL/FRAME:005674/0653

Effective date:19841224


[8]ページ先頭

©2009-2025 Movatter.jp